The prenatal identification of fetal compatibility in neonatal alloimmune thrombocytopenia using amniotic fluid and variable number of tandem repeat (VNTR) analysis

British Journal of Haematology

Volumn 91, Issue 3, 1995, Pages 742-746

  Denomme, Gregory A ^a,b   Waye, John S ^a   Borrows, Robert F ^a   Hayward, Catherine P M ^a   Warkentin, Theodore E ^a   Horsewood, Peter ^a,b   Smith, James W ^b   Jelsema, Russel D ^c   Zuidema, Laura J ^c   Kelton, John G ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b Hamilton Health Science Centre   (Canada)

^c West Michigan Perinatal and Genetic Diagnostic Center ^*  (United States)

Author keywords

NATP; platelet antigen genotyping; VNTR

Indexed keywords

THROMBOCYTE ANTIGEN;

ALLOIMMUNITY; AMNION FLUID; ARTICLE; CASE REPORT; FETUS; GENOTYPE; HUMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTOPENIC PURPURA;

AMNIOTIC FLUID; ANTIGENS, HUMAN PLATELET; BLOTTING, SOUTHERN; DNA; FEMALE; GENOTYPE; HUMAN; MALE; MINISATELLITE REPEATS; PREGNANCY; PRENATAL DIAGNOSIS; SUPPORT, NON-U.S. GOV'T; THROMBOCYTOPENIA;

EID: 0028825306     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1995.tb05379.x     Document Type: Article

References (32)

1. Platelet vulnerability in the fetus/ neonate with neonatal alloimmune thrombocytopenia
2. A1 antigen: results of a prospective study
3. Modifications to improve the effectiveness of restriction fragment length polymorphism typing
4. Fetal thrombocytopenia and its relation to maternal thrombocytopenia
5. Antenatal treatment of neonatal alloimmune thrombocytopenia
6. Recommendations for the evaluation and treatment of neonatal autoimmune and alloimmune thrombocytopenia
7. Neonatal alloimmune thrombocytopenic purpura
8. Recurrent intracranial haemorrhagesin utero in an infant with alloimmune thrombocytopenia. Case report
9. Complications of fetal blood sampling
10. Very early intracranial haemorrhage in alloimmune thrombocytopenia
11. Should all pregnant women be tested for their platelet P1A (Zw, HPA‐1) phenotype
12. utero cerebral hemorrhage in alloimmune thrombocytopenia
13. Fetal thrombocytopenia: a retrospective survey of 5,194 fetal blood samplings
14. Prenatal diagnosis of neonatal alloimmune thrombocytopenia using an allele‐specific oligonucleotide probe
15. Management of fetal and neonatal alloimmune thrombocytopenia
16. Typing of fetal platelet alloantigens when platelets are not available
17. A1 (anti‐HPA‐l a): importance of paternal and fetal platelet typing for assessment of fetal risk
18. Intrauterine fetal blood sampling; a multi‐center registry, evaluation of 7462 procedures between 1987‐1991
19. PCR for fetal platelet HPA‐1 alloantigen typing
20. Fetal blood sampling and pregnancy loss in relation to indication
21. Prenatal diagnosis of neonatal alloimmune thrombocytopenia using allele‐specific oligonucleotide probes
22. 348 cases of suspected neonatal alloimmune thrombocytopenia
23. Antenatal management of fetomaternal alloimmune thrombocytopenia: report of 15 affected pregnancies
24. Isolation and mapping of a polymorphic DNA sequence pYNH24 on chromosome 2 [D2S44]
25. Variable number of tandem repeat (VNTR) markers for human gene mapping
26. Alloimmune thrombocytopenia: fetal and neonatal losses related to cordocentesis
27. Isoimmune neonatal thrombocytopenic purpura: clinical and therapeutic considerations
28. Prenatal management of fetal alloimmune thrombocytopenia
29. Determination of human antigen frequencies in the Dutch population by immunophenotyping and DNA (allele‐specific restriction enzyme) analysis
30. Chromosome mosaicism in CVS and amniocentesis samples
31. Forensic identity testing using highly polymorphic DNA markers: current status and emerging technologies
32. Cordocentesis: overall pregnancy loss rate as important as procedure loss rate